(Q38224395)

31 August 2017

1 reference

title

Norplant: subdermal implant system for long-term contraception (English)

1 reference

levonorgestrel-releasing implant

31 August 2017

1 reference

1 reference

1 reference

D Shoupe

1

1 reference

31 August 2017

D R Mishell

series ordinal

2

1 reference

31 August 2017

language of work or name

English

0 references

publication date

1 May 1989

1 reference

American Journal of Obstetrics and Gynecology

31 August 2017

published in

1 reference

31 August 2017

volume

160

1 reference

31 August 2017

issue

5 Pt 2

1 reference

31 August 2017

page(s)

1286-1292

1 reference

Cardiovascular birth defects and antenatal exposure to female sex hormones

31 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980014-6

Tubal pregnancies in women using progestagen-only contraception

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980014-6

Contraception with long acting subdermal implants: II. Measured and perceived effects in international clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980014-6

One-Year Contraception with Norgestrienone Subdermal Silastic Implants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980014-6

Plasma levels of d-norgestrel, estradiol and progesterone during treatment with silastic implants containing d-norgestrel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980014-6

Release rates of levonorgestrel from Silastic capsules, homogeneous rods and covered rods in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980014-6

Bleeding and serum d-norgestrel, estradiol and progesterone patterns in women using d-norgestrel subdermal polysiloxane capsules for contraception

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980014-6

A prospective study of NORPLANT implants and the TCu 380AgIUD in Assiut, Egypt

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980014-6

Long-term reversible contraception with levonorgestrel-releasing Silastic rods

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980014-6

Three-year experience with NORPLANT subdermal contraception.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980014-6

Menstrual blood loss with contraceptive subdermal levonorgestrel implants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980014-6

IUDs and ectopic pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980014-6

A five-year clinical trial of levonorgestrel silastic implants (Norplant TM)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980014-6

A four-year clinical study of NORPLANT implants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980014-6

Treatment with Norplant subdermal implants inhibits sperm penetration through cervical mucus in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2889%2980014-6

10.1016/S0002-9378(89)80014-6

7 January 2021

Identifiers

DOI

1 reference

31 August 2017

1 reference